Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Clinical trial NCT03602157 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03602157
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Cutaneous Lymphoma Cutaneous Anaplastic Large Cell Lymphoma Mycosis Fungoides Sezary Syndrome Lymphomatoid Papulosis Cutaneous T Cell Lymphoma

Start date: 2018-10-29
Primary completion: 2025-12-16
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.